GEIS-新闻详情

Project to map DNA of 100,000 people in S’pore at halfway mark

2024-01-29 00:00:00.0 海峡时报-新加坡原网页

SINGAPORE – The nation’s ambitious quest to map the DNA of 100,000 people has reached the halfway mark in just over a year, with about 50,000 people’s genomes – or complete set of genes – sequenced so far.

This is a significant step towards the larger goal of mapping the genes of up to one million people by 2027.

As at mid-December 2023, about 80,000 Singapore residents between the ages of 21 and 84 had stepped forward to have a comprehensive health check done and their biological samples – including blood, urine and saliva – collected to help the country build a large population health database.

The participants’ blood samples are anonymised, packed in dry ice and sent for DNA extraction before DNA sequencing is done.

The genomic data is analysed and encrypted before it is deposited into a secure database developed by genomics technology firm Illumina.

Once all 100,000 participants’ genes have been mapped, the database is set to be one of Asia’s leading reference genome databases, as Singapore’s ethnic diversity captures more than 80 per cent of Asia’s diversity.

The collection of 100,000 genome sequences will comprise 20 petabytes, or 20 million GB, of data – equivalent to about 200,000 high-definition movies.

Get a round-up of the top stories to start your day

Thank you!

By signing up, you agree to our Privacy Policy and T&Cs.

The project, Precise-SG100K, which started in late 2022, is coordinated by the Lee Kong Chian School of Medicine.

Precise stands for Precision Health Research, Singapore, which is an entity set up to coordinate the second phase of the 10-year National Precision Medicine programme. SG100K, a comprehensive population health study of 100,000 Singaporeans, is a key partner of the programme.

Precision medicine is a targeted approach to disease treatment and prevention that takes into account individual differences in genes, environments and lifestyles. Threads of genetic material can unravel clues about a person’s risk of cancer or chronic disease, for example.

Patients who happen to carry genetic variants or “faulty genes” could have bad reactions to medications intended to treat their health problems.

One goal of the 10-year precision health programme, which ends in 2027, is to map the genes of around one million people. The programme is currently in its second phase, and the SG100K project is a key component of it.

In a website post dated Dec 11, 2023, Precise marked the milestone of completing 50,000 genome sequences by recognising its partners from the healthcare sector, academia and industry.

Among them were Illumina, which also provided the sequencing technology and equipment, and local biotech firm NovogeneAIT, which carries out the whole genome sequencing, churning out more than 760 whole genomes every week.

The 80,000 participants to date were recruited from four cohort studies, including Health for Life in Singapore (Helios), led by the Lee Kong Chian School of Medicine. Helios participants have to undergo a five-hour check-up that includes undergoing a cognitive test, having their biological samples obtained, their body composition measured, and other things. Identifiers, like their NRIC, will be removed.

The other studies are from the National University of Singapore Saw Swee Hock School of Public Health, the Singapore Eye Research Institute and the National Heart Centre Singapore.